ARIZONA HOUSE OF REPRESENTATIVES

Fifty-seventh Legislature

First Regular Session

House: HHS DP 9-2-1-0

HB 2291: opioids; containers; labeling; requirements; repeal

Sponsor: Representative Blackman, LD 7

House Engrossed

Overview

Removes the requirement that the container of a schedule II-controlled substance that is an opioid, directly dispensed by a pharmacist and not for immediate use, have a red cap.

History

Laws 2018, First Special Session, Chapter 1 outlines requirements for prescribing, administering, using and dispensing controlled substances. Specifically, it requires containers of schedule II opioids that are dispensed directly by a pharmacist and not for immediate use to have a red cap and a warning label about potential addiction, prescribed by the Arizona State Board of Pharmacy (Board).

The U.S. Drug Enforcement Administration (DEA) describes schedule II drugs, substances or chemicals as drugs with a high potential for abuse, with use potentially leading to severe psychological or physical dependence. Some examples of schedule II drugs are methamphetamine, Adderall and oxycodone (DEA).

Provisions

1. Repeals the requirement that the container of a schedule II-controlled substance that is an opioid, directly dispensed by a pharmacist and not for the immediate administration of the ultimate user, have a red cap. (Sec. 1)

2. Removes the ability of the Board or its Executive Director, if delegated by the Board, to waive the red cap requirement if implementation is not feasible because of the specific dosage form or packaging type. (Sec. 1)

3. Makes technical changes. (Sec. 1)

6. ---------- DOCUMENT FOOTER ---------

7. HB 2291

8. Initials AG/BG Page 0 House Engrossed

10. ---------- DOCUMENT FOOTER ---------